MIT Engineers Develop Nanoscale Particle for Personalized Cancer Vaccines
Engineers at MIT have developed a nanoscale particle designed for delivering personalized cancer vaccines. This innovative particle can be adapted to carry various antigens, offering a potential new approach to prevent or treat individual patients' tumors.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.
Open NewsSnap.ai